MDT Medtronic plc

NYSE medtronic.com


$ 100.81 $ 4.52 (4.69 %)    

Tuesday, 18-Nov-2025 15:53:50 EST
QQQ $ 597.82 $ -7.35 (-1.22 %)
DIA $ 462.16 $ -5.02 (-1.08 %)
SPY $ 661.61 $ -5.59 (-0.84 %)
TLT $ 89.04 $ -0.03 (-0.03 %)
GLD $ 374.33 $ 2.70 (0.73 %)
$ 100.8
$ 99.94
$ 100.77 x 230
$ 100.78 x 9
$ 99.41 - $ 102.48
$ 76.99 - $ 102.48
21,635,898
na
129.29B
$ 0.63
$ 27.75
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-26-2025 07-25-2025 10-Q
2 06-20-2025 04-25-2025 10-K
3 02-25-2025 01-24-2025 10-Q
4 11-26-2024 10-25-2024 10-Q
5 08-27-2024 07-26-2024 10-Q
6 06-20-2024 04-26-2024 10-K
7 02-27-2024 01-26-2024 10-Q
8 11-30-2023 10-27-2023 10-Q
9 08-31-2023 07-28-2023 10-Q
10 06-22-2023 04-28-2023 10-K
11 03-01-2023 01-27-2023 10-Q
12 12-01-2022 10-28-2022 10-Q
13 09-01-2022 07-29-2022 10-Q
14 06-23-2022 04-29-2022 10-K
15 03-03-2022 01-28-2022 10-Q
16 12-02-2021 10-29-2021 10-Q
17 09-02-2021 07-30-2021 10-Q
18 06-25-2021 04-30-2021 10-K
19 03-05-2021 01-29-2021 10-Q
20 12-03-2020 10-30-2020 10-Q
21 09-03-2020 07-31-2020 10-Q
22 06-19-2020 04-24-2020 10-K
23 02-28-2020 01-24-2020 10-Q
24 12-03-2019 10-25-2019 10-Q
25 08-30-2019 07-26-2019 10-Q
26 06-21-2019 04-26-2019 10-K
27 03-01-2019 01-25-2019 10-Q
28 11-29-2018 10-26-2018 10-Q
29 08-31-2018 07-27-2018 10-Q
30 06-22-2018 04-27-2018 10-K
31 03-02-2018 01-26-2018 10-Q
32 12-04-2017 10-27-2017 10-Q
33 09-01-2017 07-28-2017 10-Q
34 06-27-2017 04-28-2017 10-K
35 03-03-2017 01-27-2017 10-Q
36 12-05-2016 10-28-2016 10-Q
37 09-07-2016 07-29-2016 10-Q
38 06-28-2016 04-29-2016 10-K
39 03-09-2016 01-29-2016 10-Q
40 12-09-2015 10-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tech-stocks-drop-pharma-gains-as-sector-rotation-picks-up-whats-moving-markets-tuesday

Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New Y...

 medtronic-exec-says-bigger-portion-of-tariff-hit-in-q3-then-will-have-carryover-into-fiscal-2027

- Reuters Citing Conf Call

 this-medical-device-maker-is-seeing-high-demand-in-cardiovascular-diabetes-business

Medtronic reports strong Q2 2026 results with sales of around $9 billion, surpassing estimates. Organic growth at 5.5%.

 medtronic-ceo-says-co-now-sees-fx-tailwind-for-fiscal-2026-revenue-of-625m-725m

- Reuters Citing Conf Call

 medtronic-raises-fy2026-adj-eps-guidance-from-560-566-to-562-566-vs-563-est

GuidanceThe company today raised its FY26 revenue growth and EPS guidance.The company raised its FY26 organic revenue growth gu...

 dow-dips-over-550-points-ahead-of-economic-data-fear--greed-index-in-extreme-fear-zone

The CNN Money Fear and Greed index showed increased fear levels on Monday, while U.S. stocks closed lower.

 home-depot-medtronic-and-3-stocks-to-watch-heading-into-tuesday

US stock futures down, watch Home Depot, Medtronic, Axalta Coating, and Aecom for earnings.

 top-stocks-with-earnings-this-week-nvidia-pdd-and-more

Here's a look at the most-watched earnings reports for this week including Nvidia, PDD, Walmart, Palo Alto and more.

 jp-morgan-maintains-neutral-on-medtronic-raises-price-target-to-100

JP Morgan analyst Robbie Marcus maintains Medtronic (NYSE:MDT) with a Neutral and raises the price target from $90 to $100.

 analyst-sees-strong-medtronic-momentum-through-2026-with-buy-rating-intact

BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robus...

Core News & Articles

Orchestra BioMed's Virtue® Sirolimus AngioInfusionTM Balloon ("Virtue SAB") is the first non-coated drug-eluting ba...

 ken-griffin-to-wall-street-forget-chatgpt--hedge-fund-alpha-doesnt-need-ai

Citadel founder Ken Griffin poured cold water on Wall Street's obsession with AI at JPMorgan event saying it falls short in...

 truist-securities-maintains-hold-on-medtronic-raises-price-target-to-103

Truist Securities analyst Richard Newitter maintains Medtronic (NYSE:MDT) with a Hold and raises the price target from $96 t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION